Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Refined atrial fibrillation screening and cost-effectiveness in the German population.
Schnabel RB, Wallenhorst C, Engler D, Blankenberg S, Pfeiffer N, Spruenker NA, Buettner M, Michal M, Lackner KJ, Münzel T, Wild PS, Martinez C, Freedman B; Gutenberg Health Study investigators. Schnabel RB, et al. Among authors: munzel t. Heart. 2022 Mar;108(6):451-457. doi: 10.1136/heartjnl-2020-318882. Epub 2021 Aug 10. Heart. 2022. PMID: 34376487 Free PMC article.
Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S; AtheroGene Investigators. Schnabel R, et al. Among authors: munzel t. Eur Heart J. 2005 Feb;26(3):241-9. doi: 10.1093/eurheartj/ehi036. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15618051
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Münzel T. Schnabel R, et al. Among authors: munzel t. Circ Res. 2005 Sep 2;97(5):e53-9. doi: 10.1161/01.RES.0000181286.44222.61. Epub 2005 Aug 11. Circ Res. 2005. PMID: 16100045
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.
Blankenberg S, Godefroy T, Poirier O, Rupprecht HJ, Barbaux S, Bickel C, Nicaud V, Schnabel R, Kee F, Morrison C, Evans A, Lackner KJ, Cambien F, Münzel T, Tiret L; AtheroGene Investigators. Blankenberg S, et al. Among authors: munzel t. Circ Res. 2006 Jul 7;99(1):102-8. doi: 10.1161/01.RES.0000232324.87983.4b. Epub 2006 Jun 15. Circ Res. 2006. PMID: 16778130
Resistin, acute coronary syndrome and prognosis results from the AtheroGene study.
Lubos E, Messow CM, Schnabel R, Rupprecht HJ, Espinola-Klein C, Bickel C, Peetz D, Post F, Lackner KJ, Tiret L, Münzel T, Blankenberg S. Lubos E, et al. Among authors: munzel t. Atherosclerosis. 2007 Jul;193(1):121-8. doi: 10.1016/j.atherosclerosis.2006.05.039. Epub 2006 Jun 30. Atherosclerosis. 2007. PMID: 16814296
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S; HOPE Study Investigators. Blankenberg S, et al. Among authors: munzel t. Circulation. 2006 Jul 18;114(3):201-8. doi: 10.1161/CIRCULATIONAHA.105.590927. Epub 2006 Jul 10. Circulation. 2006. PMID: 16831981 Clinical Trial.
1,266 results